{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:12:58Z","timestamp":1777857178492,"version":"3.51.4"},"reference-count":7,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuromuscular Diseases"],"published-print":{"date-parts":[[2023,11,7]]},"DOI":"10.3233\/jnd-239005","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:21:34Z","timestamp":1699363294000},"page":"1155-1157","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Reply to F. Muntoni et al.: \u201cIn response to P.R. Clemens\n                    <i>et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy<\/i>"],"prefix":"10.1177","volume":"10","author":[{"given":"Paula R.","family":"Clemens","sequence":"first","affiliation":[{"name":"Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Research and Research Development, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"ref001","doi-asserted-by":"publisher","DOI":"10.3233\/JND-221656"},{"key":"ref002","doi-asserted-by":"publisher","DOI":"10.3233\/JND-220811"},{"key":"ref003","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1264"},{"key":"ref004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32160-8"},{"key":"ref005","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2021.0043"},{"key":"ref006","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009233"},{"issue":"6","key":"ref007","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JND-239005","volume":"10","author":"Letter to the Editor In response to P.R. Clemens et al","year":"2023","journal-title":"J Neuromuscul Dis"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JND-239005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JND-239005","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JND-239005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:52:32Z","timestamp":1777506752000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JND-239005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11,7]]}},"alternative-id":["10.3233\/JND-239005"],"URL":"https:\/\/doi.org\/10.3233\/jnd-239005","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}